Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
about
Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.Immunotherapy in Cancer: Incremental Gain or a Quantum Leap?Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review.Bilateral uveitis and macular edema induced by Nivolumab: a case report.Cytokines in Male Fertility and Reproductive Pathologies: Immunoregulation and Beyond.Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer.Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma.The diverse functions of the PD1 inhibitory pathway.Evolution of early phase clinical trials in oncology.Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges.Clinical assessment of immune-related adverse events.The Growing Incidence of Bullous Pemphigoid: Overview and Potential ExplanationsImmune-related adverse events of immune checkpoint inhibitors: a brief reviewTargeting Immune Checkpoint Molecules to Eliminate Latent HIV
P2860
Q41925180-83698699-A4C7-45A5-849D-11A6D5F94D28Q42341631-BB7C1F1D-102A-48D9-B638-C875EFB9F994Q42688279-FF438590-BA51-4040-B6A3-6DA49F1A2D8EQ47098876-46F287BC-8BE8-4EC7-BE15-F8B597C30111Q47103934-C24CF75E-2FEB-4D97-A73F-6A93ACF0FC8CQ47119885-2CC835F5-EDDD-4C9E-A1A2-5EEEE5B1F78CQ47554770-9767C798-4215-40B9-9757-79DEF4FA5B55Q47678849-92C30DE3-124B-4FAE-9C9F-284A89E63087Q47816379-8B10FE9E-0C33-4845-B28F-7E74ABB2DEEAQ52615452-36F44FAB-9C4D-4309-9944-E59DB79548EDQ55238859-8710BC2B-195F-4218-B42F-ACC2F9A00A67Q55292659-FBB43E39-5045-461D-84A9-161AC44D4A2FQ58735688-8405875D-21F8-47CD-8562-98E1047A5DB7Q59126189-53AA5312-C29D-4AE2-9613-204017148AEEQ59127701-58D02B39-D48E-4113-8D20-9D4828B19DEB
P2860
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
@en
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
@nl
type
label
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
@en
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
@nl
prefLabel
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
@en
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
@nl
P2860
P1433
P1476
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
@en
P2093
Daphne Day
P2860
P2888
P304
P356
10.1007/S40259-016-0204-3
P50
P577
2016-11-15T00:00:00Z